NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-279-2000-0-US-03 Purine nucleotide anoalogues, pharmaceutical compositions thereof, and methods of improving cardiac functions US National Stage 08/875,050 6255292 Expired PDF
NCI E-424-1987-0-US-04 Method of Treating Inflammation with Antibodies to Neutrophil Chemotactic Factor (As Amended). US DIV 08/935,560 5925352 Expired PDF
NICHD E-085-1996-0-US-01 NUCLEOTIDE AND AMINO ACID SEQUENCES OF THE BRX GENE AND GENE PRODUCT, AND USES THEREOF US 60/059,621 Abandoned
NCI E-053-1996-0-US-03 IMMORTAL HUMAN PROSTATE EPITHELIAL CELL LINES AND THEIR APPLICATIONS IN THE RESEARCH AND THERAPY OF PROSTATE CANCER US National Stage 08/913,770 6982168 Abandoned PDF
NCI E-132-1988-0-US-06 8-CI Camp as Anti-Cancer Drug US CON 08/937,020 5902794 Abandoned PDF
NIAID E-049-1998-0-PCT-02 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES PCT PCT PCT/US1997/016718 Expired
NIAID E-049-1998-0-CA-05 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES CA National Stage 2265554 Abandoned
NCI E-160-1996-0-US-01 METHODS FOR USE OF INTERLEUKIN 4 (IL-4) AND TUMOR NECROSIS FACTOR ALPHA (TNF-A) TO TREAT HUMAN IMMUNODEFICIENCY VIRUS INFECTION US 60/059,359 Abandoned
NIAID E-089-1997-1-US-01 PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES US 60/059,385 Abandoned
NIAID E-049-1998-0-AU-03 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES AU National Stage 44278/97 Abandoned
NIAID E-049-1998-0-BR-04 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES BR National Stage PI9712138-0 Expired
NIAID E-094-1999-0-US-01 Attenuated Respiratory Syncytial Viruses US 60/059,552 Abandoned
NHLBI E-263-1997-0-US-02 SPONTANEOUS BREATHING APPARATUS AND METHOD US ORD 08/933,003 Abandoned
NHLBI E-263-1997-0-US-01 SPONTANEOUS BREATHING APPARATUS AND METHOD US 60/059,251 Abandoned
NIAID E-176-1996-0-PCT-02 No_Patent_Title PCT PCT PCT/US97/16116 Abandoned
NIDCR E-171-1996-0-EP-07 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN EP National Stage 97941660.9 Abandoned
NIDCR E-171-1996-0-DE-09 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN DE EP 97941660.9 Abandoned
NIDCR E-171-1996-0-FR-10 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN FR EP 97941660.9 Abandoned
NIDCR E-171-1996-0-GB-11 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN GB EP 97941660.9 Abandoned
NIDCR E-171-1996-0-AU-05 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN AU National Stage 43521/97 Abandoned
NIDCR E-171-1996-0-CA-06 TARGETING ANTIGENS TO THE MHC CLASS I PROCESSING PATHWAY WITH ANTHRAX TOXIN FUSION PROTEIN CA National Stage 2265852 Abandoned
NIDCR E-171-1996-0-US-02 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN US ORD 08/937,276 6592872 Abandoned PDF
NIAID E-188-1992-0-US-04 REGULATION OF T CELL EFFECTOR ACTIVITY BY T CELL RECEPTOR LIGANDS WITH INCOMPLETE AGONIST (MIXED AGONIST-ANTAGONIST) PROPERTIES US CON 08/931,192 Abandoned
NINDS E-132-1996-0-US-02 AN Immunotoxin (mAB-RICIN) For The Treatment of Focal Movement Disorders US ORD 08/937,266 Abandoned
NIAID E-248-1997-0-US-01 PLASMODIUM FALCIPARUM GENE LINKED TO CHLOROQUINE RESISTANCE IN HUMAN MALARIA US 60/058,895 Abandoned
NCI E-194-1994-1-US-02 Substituted O6-Benzylguanines and 6 (4)-Benzyloxypyrimidines US DIV 08/927,846 5916894 Abandoned PDF
NIDDK E-145-1995-0-PCT-02 USE OF FUNCTIONAL N-METHYLE-D-ASPARTATE ANTAGONISTS TO AMELIORATE OR PREVENT AMINOGLYCOSIDE-INDUCED OTOTOXICITY PCT PCT PCT/US97/16605 Abandoned
NIDCR E-066-1996-0-EP-06 AAV4 VECTOR AND USES THEREOF EP National Stage 97945204.2 Abandoned
NCI E-268-1997-0-US-01 MUCOSAL CYTOTOXIC T LYMPHOCYTE RESPONSES US 60/058,523 Abandoned
NIDCR E-066-1996-0-CA-04 AAV4 VECTOR AND USES THEREOF CA National Stage 2265460 Abandoned
NIDCR E-066-1996-0-AU-03 AAV4 VECTOR AND USES THEREOF AU National Stage 46456/97 Abandoned
CC E-041-1997-0-US-01 Method of Amplifying DNA and RNA Mismatch Cleavage Products US 60/058,419 Abandoned
NCI E-035-1994-2-US-03 ISOLATION OF CELLULAR MATERIAL UNDER MICROSCOPIC VISUALIZATION US DIV 08/925,894 6010888 Abandoned PDF
NCI E-230-1997-0-US-01 Human Papilloma Virus Anti-Sense Oligonucleotides US ORD 08/929,140 6084090 Abandoned PDF
NCI E-170-1996-0-PCT-02 THERAPEUTIC CHEMOKINE ANTAGONISTS PCT PCT PCT/US1997/015594 Abandoned
NEI E-027-2000-0-US-01 Method For Ameliorating An Allergic Reaction US ORD 2024-11-02 Abandoned
NIAID E-154-1993-0-US-03 IMMUNOLOGIC ENHANCEMENT WITH INTERMITTENT INTERLEUKIN-2 THERAPY US FWC 08/922,218 6190656 Expired PDF
CC E-223-1993-0-US-04 METHOD AND SYSTEM FOR MULTIDIMENSIONAL LOCALIZATION AND FOR RAPID MAGNETIC RESONANCE SPECTROSCOPIC IMAGIN US DIV 08/917,959 5879299 Abandoned PDF
NCI E-185-1997-0-US-01 ISOLATION, CLONING, DETECTION, AND BIOLOGIC FUNCTION OF WILD TYPE, ATTENUATED, AND DOMINANT NEGATIVE VARIANT cDNA OF STAT6:,STAT6B, ... US 60/056,075 Abandoned
NIAID E-032-1993-1-US-02 HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS US DIV 08/920,100 6685942 Expired PDF
NLM E-130-1997-0-US-01 POLYNUCLEOTIDE INHIBITION OF RNA DESTABILIZATION AND SEQUESTRATION US 60/056,683 Abandoned
NCI E-108-1995-0-US-03 Cellular Apoptosis Susceptibility protein (CSP) and Antisense CSP Cellular Apoptosis Susceptibility Protein (CSP) US DIV 08/918,190 6072031 Abandoned PDF
NCI E-163-1993-2-US-02 Immunotoxin Containing a Disulfide-Stablized Antibody Fragment Joined to a Pseudomonas Exotoxin That Does Not Require Proteolytic Activation US National Stage 08/809,668 5980895 Expired PDF
NIAMS E-257-1997-0-US-01 IDENTIFICATION OF THE GENE CAUSING FAMILIAL MEDITERRANEAN FEVER US 60/056,217 Abandoned
NCI E-335-1994-2-US-01 ISOLATION OF ESSENTIAL BACTERIAL GENES, DETECTION OF BACTERIAL SPECIES AND DEVELOPMENT OF ANTIMICROBIAL AGENTS BASED ON STRUCTURE AND... US ORD 08/915,498 6132954 Abandoned PDF
CC E-040-1997-0-US-01 METHODS AND APPARATUSES FOR PROCESSING SYNTHESIZED MODELS OF COMPLEX MEDICAL STRUCTURES US 60/056,452 Abandoned
NIBIB E-235-1995-0-EP-03 SPATIAL AND TEMPORAL CONTROL OF GENE EXPRESSION USING A HEAT SHOCK PROTEIN PROMOTER IN COMBINATION WITH LOCAL HEAT EP National Stage 97940696.4 Expired
NIBIB E-235-1995-0-EP-10 SPATIAL AND TEMPORAL CONTROL OF GENE EXPRESSION USING A HEAT SHOCK PROTEIN PROMOTER IN COMBINATION WITH LOCAL HEAT EP DIV 97940696.4 Abandoned
NCI E-144-1996-0-DE-06 NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES DE EP 97937243.0 Abandoned
NCI E-144-1996-0-FR-07 NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES FR EP 97937243.0 Abandoned